Latest Information Update: 03 Mar 2010
At a glance
- Originator Solvay
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cardiovascular disorders
Most Recent Events
- 06 May 2005 This compound is still in active development
- 13 Dec 2001 New profile
- 13 Dec 2001 Preclinical development for Cardiovascular disorders (Unknown route)